AGP Executive Report
Last update: 2 hours agoIndustry: Stadler won a contract worth more than CHF300 million to build 10 trains for Saudi Arabia, with production in Switzerland. Healthcare: Roche reported positive Phase III results for experimental eye drug vamikibart, with vision gains sustained over 52 weeks. Corporate Moves: Sika acquired UK polymeric sands maker Azpects Group, while Swiss medical-technology group Schiller opened a plant in Bosnia. Swiss Economy: Consumers are still spending despite rising prices, and Raiffeisen has raised its growth forecast for the country. Risks: A cyberattack on a software supplier affected Bern pension funds, highlighting the exposure of financial institutions to digital disruption.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.